No, this is not another post concerning a potential OHIM scandal (see here). The IPKat's good friend Alfred Strahlberg has contacted the Kat with an interesting observation concerning the numbers of oppositions filed against "normal" Community Trade Mark applications (average 17.45%) and the significantly lower number of oppositions filed against European Community designations of international marks under the Madrid system (8.3%). Alfred has helpfully and with Swiss precision calculated the above percentage numbers for the Kat, who in turn apologises that the picture below is a little blurry. So what is the reason for the discrepancy in the numbers of oppositions filed against CTMs and IRs designating the EU? Alfred speculates that
"...one reason may be because the republication of an IR occurs six months prior to the opposition period and the end date of the opposition period is not indicated, making it hard to monitor. Also CTM Online as regards IRs is sometimes not updated when the opposition period is open."
"Could it also be that IR marks, as they need a basis registration/application, are less likely to be opposed at OHIM, but rather at the central level? At least if I have a choice as opponent - i.e., I also have a mark in the "home country" of the IR - I'd probably prefer to oppose the base registration and kill it once and for all."
"Users of MyPage, the password-protected platform making it easier to do business with OHIM, will have access to a new feature allowing them to track the progress of CTM applications as well as international applications from 1 October. [IPKat: should this read "European Community designations of international trade mark registrations"...? OHIM's explanatory leaflet refers to "International Registrations".]
Using the CTM Watch service, users will be able to select any CTM application or international application and receive an e-mail alert when the application status changes. For example, a user can ask to be informed when a CTM/IR is published or registered. For more information on CTM Watch see our leaflet."